Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-112486
Filing Date
2025-11-14
Accepted
2025-11-14 16:05:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11700
  Complete submission text file 0001104659-25-112486.txt   13627
Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 415-877-4887
Foresite Capital Fund VI LP (Filed by) CIK: 0001932516 (see all company filings)

EIN.: 881506258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94039 | Film No.: 251485864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)